학술논문

SIX4, a potential therapeutic target for estrogen receptor-positive breast cancer patients, is associated with low promoter methylation level
Document Type
Article
Source
In: Epigenomics. (Epigenomics, 1 September 2023, 15(18):911-925)
Subject
Language
English
ISSN
1750192X
17501911